Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 13,714 shares at $17.72 ($243K) on 2022-11-15, disclosed to the SEC on 2022-11-17.
Open-market sale of $243k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.72 | 6,857 | $122K | 50.0% |
| 2 | $17.72 | 6,857 | $122K | 50.0% |
| Total | $17.72 avg | 13,714 | $243K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |